Calcagnile Olga, Holmén Anders, Chew Michelle, Undén Johan
Scand J Trauma Resusc Emerg Med. 2013 Jul 6;21:52. doi: 10.1186/1757-7241-21-52.
Biomarkers of brain damage and head injury are potentially useful tools in the management of afflicted patients. Particularly S100B has received much attention and has been adapted into clinical guidelines. Alcohol intoxication and higher age (65 years and over) have been used as risk factors for serious complications following head injury. The effect of these factors on S100B levels has not been fully established in a relevant patient cohort.
We prospectively included 621 adult patients with mild traumatic brain injury (TBI) and S100B sampling. Mild TBI was defined as Glasgow Come Scale 14-15 with loss of consciousness and/or amnesia, but without high-risk factors for intracranial complications. These patients would normally require CT scanning according to local and most international guidelines. S100B was sampled within 3 hours following trauma.
280 patients (45%) were intoxicated by alcohol. Alcohol intoxication had no effect on S100B levels (p = 0.65) and the performance of S100B remained unchanged in these patients. 115 patients (22%) were 65 years or older with elevated S100B levels being more common in this group compared to patients under 65 (p = 0.029). Although the sensitivity of S100B was unchanged in older patients, the specificity was poorer.
S100B can be used reliably in mild TBI patients with alcohol intoxication. The clinically utility of S100B in older patients may be limited by very poor specificity leading to only a small decrease in CT scanning.
脑损伤和头部损伤的生物标志物在患病患者的管理中可能是有用的工具。特别是S100B受到了广泛关注,并已被纳入临床指南。酒精中毒和较高年龄(65岁及以上)被用作头部损伤后严重并发症的危险因素。这些因素对S100B水平的影响在相关患者队列中尚未完全明确。
我们前瞻性纳入了621例患有轻度创伤性脑损伤(TBI)并进行S100B采样的成年患者。轻度TBI定义为格拉斯哥昏迷量表评分为14 - 15分,伴有意识丧失和/或失忆,但无颅内并发症的高危因素。根据当地和大多数国际指南,这些患者通常需要进行CT扫描。S100B在创伤后3小时内进行采样。
280例患者(45%)酒精中毒。酒精中毒对S100B水平无影响(p = 0.65),且这些患者中S100B的性能保持不变。115例患者(22%)年龄在65岁及以上,与65岁以下患者相比,该组中S100B水平升高更为常见(p = 0.029)。尽管老年患者中S100B的敏感性不变,但其特异性较差。
S100B可可靠地用于酒精中毒的轻度TBI患者。S100B在老年患者中的临床效用可能因特异性非常差而受到限制,导致CT扫描仅略有减少。